Personalised Medicine - Bespoke Healthcare is the Latest Trend

Authors

  • Laura Mangan Editor-in-Chief, Trinity Student Medical Journal

Keywords:

Medicine

Abstract

NIL

References

1 European Science Foundation. Personalised Medicine for the European Citizen - towards more precise medicine for the diagnosis, treatment and prevention of disease. (2015). Available at: http://www.esf.org/index.php?elD=tx_nawse- curedl&u=0&file=fileadmin/be_user/CEO_Unit/Forward_Look/ iPM.pdf&t=1426213045&hash=ce6cb2ebd43e2a11bb16071b- 12110514325c5b08 (Acessed: 12th March 2015).
2 Welter D, et al. The NHGRI GWAS Catalog, a curated re-source of SNP-trait associations. Nucleic Acids Res. 2014;42:1001– 1006.
3 Ortega VE, Meyers DA, Bleecker ER. Asthma pharmaco- genetics and the development
of genetic profiles for personalized medicine. Pharmgenomics Pers. Med. 2015;8:9-22.
4 Shukla S, Bhargava S, Somasundaram K. Cancer gene signatures in risk stratification: use in personalized medicine. Curr. Sci. 2014;107(5):815-823.
5 Piccart-Gebhart MJ, Sotiriou C, Adjuvant chemotherapy – yes or no? Prognostic markers in early breast cancer. Ann. On- col. 2007;18(12):2–7.
6 Cusumano PG, et al. European inter-institutional im- pact study of MammaPrint. Breast. 2014;23:423-428
7 Abul-Husn NS, et al. Implementation and utilization of genetic testing in personalized medicine. Pharmgenomics Pers. Med. 2014;7:227–240.
8 Personalised Medicine Coalition. The Case for Personalized Medicine (4th Edition; 2014) Available at: http://www.per- sonalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/ pmc_the_case_for_personalized_medicine.pdf (Accessed: 12th March 2015).
9 Bosch R, Rosich L, The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel Prize. Pharmacology. 2008;82(3):171–179.
10 Ramsey BW, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365(18):1663–1672.
11 National Centre for Pharmacoeconomics. Cost-effectiveness of Ivacaftor (KalydecoTM) for the
treatment of cystic fibrosis in patients age 6 years and older who have the G551D mutation. (2013) Available at: http://www.ncpe. ie/wp-content/uploads/2012/08/Ivacaftor-Summary.pdf (Accessed: 11th March 2015).

Downloads

Published

2015-01-01

How to Cite

Mangan, L. (2015). Personalised Medicine - Bespoke Healthcare is the Latest Trend. Trinity Student Medical Journal , 16(1), Page 6–8. Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/1868

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.